Research at Cincinnati Children’s advances pediatric interventional endoscopy, studying EUS and ERCP to improve outcomes and reduce complications in children.
AI-driven analysis of multimodal data at Cincinnati Children’s may advance precision medicine for children with inflammatory bowel disease.
New research from Cincinnati Children’s aims to refine initial biologic selection for pediatric Crohn’s disease using a blood-based biomarker.
Cincinnati Children’s launches a pivotal clinical trial for KiteLock therapy—a breakthrough approach to reducing catheter complications in pediatric intestinal failure patients.
Cincinnati Children’s shares outcomes and research advances from 100 TPIAT surgeries, highlighting multidisciplinary care for children with severe pancreatitis.
Cincinnati Children’s and Akron Children’s mark one year of collaboration to expand access to expert pediatric liver care across Northeast Ohio.
Discover how Cincinnati Children’s is improving eosinophilic gastrointestinal disorder (EGID) care with FDA-approved drugs, transnasal endoscopy, and advanced diagnostic scoring systems.
Cincinnati Children’s researchers use AI and imaging to predict IBD outcomes, aiming to improve diagnosis, therapy selection, and patient care.
Discover how Cincinnati Children’s DGBI program is transforming care for complex GI disorders through multidisciplinary treatment and cutting-edge research.